Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway.

Article Details

Citation

Copy to clipboard

Volpi S, Liu Y, Aguilera G

Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway.

J Mol Endocrinol. 2006 Jun;36(3):581-90.

PubMed ID

16720725 [ View in PubMed

]

Abstract

Previous studies show that binding of nuclear proteins to GAGA repeats (GAGA box) in the vasopressin type 1b receptor (V1bR) promoter is essential for transcriptional initiation of the gene. To determine whether increased vasopressin (VP) during stress activates V1bR expression through the GAGA box, we examined the effects of VP on GAGA binding activity and on the ability of the V1bR promoter to recruit RNA polymerase in the hypothalamic cell line, H32. In chromatin immunoprecipitation assays, VP induced RNA polymerase II recruitment by the wild type V1bR promoter but not by a construct with the major GAGA box deletion. VP (10 min) also increased binding of nuclear proteins to radiolabeled GAGA oligonucleotides in electromobility shift assays. VP-induced GAGA binding activity was potentiated by the protein kinase C inhibitor, calphostin C, and was prevented by the MEK inhibitor, UO126, and the epidermal growth factor receptor (EGFR) inhibitor, AG1478, suggesting that VP activates GAGA binding through transactivation of the EGFR. This was confirmed by western blot experiments showing rapid increases in phospho ERK after incubation with VP, an effect that was potentiated by calphostin C and inhibited by UO12 and AG1478, as well as by the ability of VP to phosphorylate the EGFR. Using receptor selective VP analogs we showed that both V1aR and V1bR subtypes can mediate GAGA binding activation in H32 cells. This study demonstrates that VP stimulates GAGA binding to the V1bR promoter through transactivation of the EGFR and MAP kinase. The data support the hypothesis that VP contributes to pituitary V1bR upregulation during stress through GAGA binding-mediated transcriptional activation.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Lypressin	Vasopressin V1b receptor	Protein	Humans	Yes	Not Available	Details
Terlipressin	Vasopressin V1b receptor	Protein	Humans	Yes	Agonist	Details
Vasopressin	Vasopressin V1b receptor	Protein	Humans	Yes	Agonist	Details